Population Boom Bucking Up Saudi Arabian Healthcare SectorBy: Shushmul Maheshwari
Population Boom Bucking Up Saudi Arabian Healthcare Sector
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|Saudi Arab is amongst the world’s fastest growing healthcare markets, and the biggest factor spurring this growth is the rapidly expanding population of the country, according to “Saudi Arabian Healthcare Market Forecast to 2012”, a new research report by RNCOS. |
The report finds that despite healthy investment in new bed installations, the rate of population growth has significantly outpaced the rate of bed growth from early 1990s to 2008, leading to a fall in the bed to population ratio from 2.55 beds per thousand population to the present 2.36 beds per thousand population.
Currently, the country is witnessing maximum growth in the population segment at or above 65 years of age. The report forecasts this population segment to expand by 15% between 2008 and 2012, outpacing the 10% increase in the total population. With increasing aging population, the prevalence of a number of chronic diseases such as obesity, diabetes, cardiovascular and dementia will grow exponentially in future. This will significantly push the demand for hospital services, pharmaceuticals and medical devices in future.
Apart from the shortage of beds, the fast expanding population will also create a shortage of healthcare professionals in the country. Most of the healthcare professionals in the country are foreign nationals with high turnover rates. As a result, the government has taken a number of steps to improve its medical education infrastructure. However, the number of medical graduates passing out in the foreseeable future is not likely to match the demand emerging from the ever-increasing population. This will open up big opportunities for the education services market in Saudi Arab.
“Saudi Arabian Healthcare Market Forecast to 2012” gives an extensive and objective analysis on the Saudi Arab healthcare market. It has segmented the healthcare industry under the heads hospital services, pharmaceuticals and medical devices. Analysis as well as statistics on these segments regarding the market size, demand, supply, segmentation and key players has been given in this report.
An analysis on the future directions, supplemented with both facts and figures has also been done by the report. Thus, the research study serves as a useful guide for healthcare companies, government officials, consultants and investors who are planning to foray into the Saudi Arab healthcare market.
||Saudi Arabian Healthcare Market Forecast to 2012, Saudi Arabian Healthcare Market, Healthcare Market of Saudi Arabia, Opportunities in Saudi Arabian Healthcare Market, Growth of Saudi Arabian Healthcare Market
||Health and Fitness
||Mar 23, 2009
|Article Contact Name
||Shushmul Maheshwari || send email to Shushmul Maheshwari
Other links at Health and Fitness
Discover the true meaning of yoga With Swami Ramdev
In taking any modern yoga class, you will find parallels to ballet. Like ballet, the promise of poise, grace and flexibility encourages much interest. Yet if yoga is like any other exercise, it is only at first glance. Underneath the coveted health and fitness benefits of modern yoga practice are the roots of a great spiritual tradition blending cultures and religions.
Asanas urge us to see our body as divine, and to nurture health in this mortal temple. Yogic adepts understand that their body is flawed, however slender and toned it may look externally. This acknowledgement leads to less judgement of otherâ��s bodies. However pleasing to the eye a yogis shape may be, the same vedic texts that encourage the practice of yoga for health, also remind us that true â��liberationâ�� comes from being free of the cycle of rebirth-free of the physical form.
Yogic postures work in contrast to the western notion of exercise. Here we see exercise as an end, such as an end to overweight and fatigue. Yoga is different. While in most forms of exercise the physical results are the sole goal, in yoga the soul is the goal. The ancient tradition of yoga exercise stands apart in its doctrines. The ancient yoga texts insist that the mind and spirit are more important than the physical body. While many other eastern forms of mind-body fitness also encourage this awareness, no other physical practice has the ultimate goal of union with the divine. In yoga, the process of attaining this union is as important as the actual attainment.
Yoga practice is not a means to an end. It is an end in of itself. Even distinguished from vedas and sutras, the modern practice of yoga posture is a beautiful and calming pursuit. Though modern yoga practice makes little mention of the scriptures that it is based on, the experience of union and compassion can be woven into each pose. In doing this we are enhancing more than our practice, we are improving our life.
Yoga With Swami Ramdev
Swami Ramdev Born in year 1974 also known as Baba Ramdev is in fact an Indian Hindu swami and an passionate admirer of Swami Vivekananda and Netaji Subhas Chandra Bose. He is mainly well-known for his efforts into popularizing Yoga Practices in different part of world. He is as well one of the founders of the Divya Yoga Mandir Trust that aims to popularize Yoga and offer Ayurvedic treatments.
His camps are also attended by a great number of people. Over 85 million people follow his particular yoga camps via TV channels, and video. Yoga practice is not a means to an end. It is an end in of itself. Even distinguished from vedas and sutras, the modern practice of yoga posture is a beautiful and calming pursuit His yoga teaching sessions are great for the masses and so free for all. His stated main principle in life that is to be of help to all casts members. The sessions are conducted with the minimal to excessive charges, and depending on the place where the camp that is also being offered.
Panic attack what you should know about
here will details those 10 of the most common symptoms of a panic attack so that you can further recognize whether you or a loved one is actually suffering from them. It will also give you that some advice as to how to deal with the basic problem of panic and anxiety disorders quickly and also effective.
Here is a given below list of 10 Symptoms of a Panic Attack sysmptoms
2. Dizziness or light-headiness
3. Shaking visibly or also feeling like you are shaking inside
4. Chills or hot flushes
5. Heart palpitations, flutters, and chest pain or irregular heart beats
6. Your skin losing color
7. Having a choking sensation or feeling like you have a lump into throat, or that having swallowing problems
8. Ringing in your ears
9. Being really desperate to also defecate or urinate
10. Pains in your muscles, especially when if it is concentrated in the neck or the shoulder regions
These are that a few of the more well known symptoms of a panic attack. If you believe you might have experienced an attack or are likely to then it would be a good idea to visit a doctor. However, you must also be careful since the first thing that many doctors do is to prescribe drugs for dealing with this problem.
The last thing you want to do is to be feeling like you are coping with the problem with the help of prescribed drugs, only to be hit with a bunch of side effects and being addicted to the very medication that is supposed to be helping you.
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
According to “Japanese Generic Market Forecast to 2013”, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register Ą 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government, which in a desperate bid to limit its healthcare costs, is introducing a number of generic-friendly policies. Other factors such as a large number of patent expiries and the largely un-penetrated nature of the market are also contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the top six manufacturers accounting for 56% of the total market in 2007. But opening up of the market and introduction of a number of generic-friendly reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number challenges to deal with. Generic drugs are still regarded as cheap, low quality alternatives of branded drugs. Thus, both physicians and patients are skeptic regarding their safety and efficacy. A number of awareness and educational programs, however, are expected to increase their awareness in future.
Despite these challenges, our forecast models suggest that the generic drugs market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in Japan. It investigates both the past and present trends in the generic market, but its focus is on the future trends shaping the industry. The report also investigates the performance of various players in the Japanese pharmaceutical and generic markets, and analyzes the competitive landscape in these markets. Based on various present and future indicators, the future scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese pharmaceutical and generic markets. This section describes market shares and growth of key pharmaceutical and generic players in Japan. Profiles of the top six generic manufacturers have been provided in the report.
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/
RNCOS Releases a New Report- Global Cancer Treatment Forecast to 2012
RNCOS has recently added a new Market Research Report titled, "Global Cancer Treatment Forecast to 2012" to its report gallery. This report is a comprehensive study on the global cancer market and gives statistics and analysis on cancer prevalence, market size, market structure, key drug segments, market share of key players and drugs, major opportunity areas and trends in technology development. Both the past and current market trends have been covered in the report along the factors that are expected to impact the market in future. This report provides answers to a number of questions vital for firms looking for making an investment into the sector.
Other than this, the shooting rate of Internet adoption across the world and rising threats on Internet (like malware, spam and hack attacks) are bolstering the demand for IT security solutions. Moreover, IT security attacks are becoming increasingly sophisticated, requiring continuous monitoring and updating the existing IT security solutions.
High number of unmet needs and an ever-increasing prevalence of cancer has created a gold rush among drug companies to enter the cancer market. Here, launching a drug successfully is risky, however, if launched, commercial gains completely surpass the expenditures incurred.
Cancer represents the fastest growing therapy segment in the pharmaceutical market. This segment has become the centre of focus for drug firms and investors, and has garnered more attention than any other therapy segment; nearly every mid-size and large pharmaceutical/biotech company today is linked to a cancer pipeline.
Drugs available in the market today do give some respite to patients but fail to address a number of complications. So manufacturers are working to solve the problem and in future, we may see a number of drug launches which will significantly reduce the complications and increase life expectancy significantly.
- From more than 12 Million newly diagnosed cancer cases in 2007, the number of newly diagnosed global cancer cases is expected to reach over 17 Million by 2020.
- Growing at a CAGR of 12.3% between 2007 and 2012, the global market for cancer drugs is expected to cross US$ 78 Billion by 2012.
- Cancer vaccines and antiangiogenics will record the fastest growth rate between 2007 and 2012.
- Drug manufactures are now focused on developing target therapies. These drugs attack target cells and thus limit the severity of side effects.
- The US is the largest market for cancer drugs, followed by Europe and Japan.
- Drugs for cancer represent the largest therapy area under clinical development; however, when it comes to approval rates, drugs for cancer have the worst approval rates.
Key Issues Analyzed
- Evaluation of past, current and future market trends.
- Discussion on major cancer drugs and their markets.
- Future forecast of the cancer market.
- Analysis of various challenges and opportunities for the industry.
- Categories of players operating in the market and their present and future revenue forecast.
- Analysis of key Geographical markets.
Research Methodology Used
The information given in the report has been sourced from various credible sources like books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.
The analysis methods used in the report include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
For more information visit: http://rncos.com/Report/IM130.htm
Current Industry News: http://www.rncos.com/Blog/
Protocol Link, Inc
Protocol Link, Inc. is a leading global project management and consulting firm offering comprehensive advisory services to regulated life sciences companies worldwide, including regulatory compliance, validation, and quality assurance services.
At Protocol Link, we strive to offer the best of both quality and efficiency. It’s how we’ve been doing business since 1996. The right way. Knowing that our clients are counting on us. We have maintained our track record of doing our very best to get it right the first time, every time, for 11-plus years. 95% of our business represents repeat engagements with satisfied clients, reflecting our client focus.
We offer an even balance of regulatory expertise and experience. Our consultants are hands-on, analytical, yet strategic. We are driven by providing the best solutions to help our clients meet their business goals. With more than 450 projects completed to date, representing engagements in the US, Australia, Belgium, France, Germany, Italy, Japan, Mexico, The Netherlands, Puerto Rico, Romania, and South Korea, Protocol Link is building a strong worldwide presence. Over the years we have successfully managed projects and advised dozens of firms ranging from Fortune 50 companies to start-up biotechnology firms by offering the following list of specialties:
Compliance Planning and Management
Compliance and Readiness Audits
Quality Systems Development
Validation (Plans, Systems, Processes)
CGMP / QA Documentation
Regulatory Affairs & Submission Assistance
Exception Investigations and CAPA
FDA and EU Liaison
Inspectional Observations Preparation Critical Systems / Facilities
SVP and LVP Processes
Solid Dosage Manufacturing
Packaging and Labeling
Analytical Method Development
Diagnostics and Medical Devices
Contract Manufacturing Oversight
Change Control / Change Management
We invite you to visit our Web site at www.protocollink.com for additional information about our company and the services that we offer. We look forward to serving you.